| Authors: |
Ravindra N; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lack J; Integrated Data Sciences Section, National Institutes of Health, Bethesda, MD., Dalgard CL; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD., vanCollenburg E; Bio-Rad Laboratories, Digital Biology Group, 5731, W. Las Positias Blvd, Pleasanton, CA., Corner A; Bio-Rad Laboratories, Digital Biology Group, 5731, W. Las Positias Blvd, Pleasanton, CA., Beppu L; Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Erba H; Duke University School of Medicine, Durham, NC., Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Radich JP; Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Dillon LW; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC. |
